{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:45:10Z","timestamp":1795020310472,"version":"4.10.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Substance use in pregnancy is increasing in the United States (US), although little is know about co-occurring substance use disorders in pregnancy. Our objective was to determine the prevalence and patterns of co-occurring substance use disorders identified at delivery hospitalizations among US women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using data from the National Inpatient Sample, a nationally representative sample of hospitalizations in the US, we identified females ages 15 to 44 years with a delivery hospitalization from 2007 to 2016 (weighted N = 38 million). We identified diagnoses for use of any of the following substance use disorders: alcohol, amphetamines, cannabis, cocaine, opioids, sedatives, or tobacco. Using multivariable regression, we calculated the weighted adjusted prevalence of additional substances used within each specific substance use disorder category.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seven percent of women were diagnosed with any substance use disorder at delivery hospitalization (6.5% tobacco, 1% cannabis, 0.5% opioids, and &lt;1% amphetamines, alcohol, cocaine, and sedatives). Among those with any substance use disorder diagnosis, the adjusted prevalence of any co-occurring use disorder was greatest for those who used alcohol (69%), cocaine (69%), amphetamines (63%), and opioids (62%). Among pregnant women who were diagnosed with cocaine, amphetamines, alcohol or opioid use disorder, tobacco (&gt;45% in all groups), and cannabis (&gt;10% in all groups) were the most common additional substances used. Tobacco and cannabis use disorders were commonly diagnosed together.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Co-occurring substance use disorders are common among women with any substance use disorder in pregnancy. Findings support the need for public health efforts to monitor and address multiple, concurrent use of substances in pregnancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/adm.0000000000000792","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T23:01:53Z","timestamp":1607036513000},"page":"504-507","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States"],"prefix":"10.1097","volume":"15","author":[{"given":"Marian","family":"Jarlenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Krans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"issue":"(31)","key":"R2-20250526","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine-and opioid-affected births: Incidence, outcomes, and costs, United States, 2004-2015","volume":"109","author":"Admon","year":"2018","journal-title":"Am J Public Health"},{"issue":"(24)","key":"R4-20250526","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2017.17225","article-title":"Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009-2016","volume":"318","author":"Young-Wolff","year":"2017","journal-title":"JAMA"},{"issue":"(6)","key":"R5-20250526","first-page":"1","article-title":"Deaths: Leading causes for 2017","volume":"68","author":"Heron","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"(3)","key":"R6-20250526","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1542\/peds.2012-3931","article-title":"Committee on substance abuse, committee on fetus and newborn. prenatal substance abuse: Short- and long-term effects on the exposed fetus","volume":"131","author":"Behnke","year":"2013","journal-title":"Pediatrics"},{"issue":"(6)","key":"R7-20250526","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/AOG.0000000000003279","article-title":"Pregnancy-associated death in Utah: Contribution of drug-induced deaths","volume":"133","author":"Smid","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"(5)","key":"R8-20250526","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00952990.2011.596982","article-title":"Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial","volume":"37","author":"Back","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"(1)","key":"R9-20250526","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/add.15116","article-title":"Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration","volume":"116","author":"Lin","year":"2021","journal-title":"Addiction"},{"issue":"(5)","key":"R10-20250526","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"(2)","key":"R11-20250526","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am J Public Health"},{"issue":"(4)","key":"R13-20250526","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10995-007-0256-6","article-title":"An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity","volume":"12","author":"Kuklina","year":"2008","journal-title":"Matern Child Health J"},{"issue":"(3)","key":"R14-20250526","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ije\/dyu029","article-title":"Estimating predicted probabilities from logistic regression: Different methods correspond to different target populations","volume":"43","author":"Muller","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.2017.303825","article-title":"Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons","volume":"107","author":"Jarlenski","year":"2017","journal-title":"Am J Public Health"},{"issue":"(6)","key":"R16-20250526","first-page":"1","article-title":"Trends in smoking before, during, and after pregnancy--pregnancy risk assessment monitoring system, United States, 40 sites","volume":"62","author":"Tong","year":"2013","journal-title":"MMWR Surveill Summ"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000000792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T20:03:01Z","timestamp":1748289781000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000000792","relation":{},"ISSN":["1932-0620","1935-3227"],"issn-type":[{"value":"1932-0620","type":"print"},{"value":"1935-3227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]}}}